Skip to content
MedsAcross

Medicine

Quzyttir 10 mg/1 mL injection

Cetirizine · Intravenous · Esteve Pharmaceuticals
Available on requestPrescription onlyUS FDA

Quzyttir 10 mg/1 mL injection is a prescription medicine containing Cetirizine for intravenous use, marketed by Esteve Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

QUZYTTIR (cetirizine hydrochloride injection) should be stored at 20°C to 25°C…

Key facts

Active ingredient (INN)
Cetirizine
Brand
Quzyttir
Strength
10 mg/1 mL
Dosage form
Injection
Route
Intravenous
Packs
1 vial of 1 mL, 25 vials of 1 mL and 1 more
Marketing authorisation holder
Esteve Pharmaceuticals
Manufacturers
Esteve PharmaceuticalsTerSera Therapeutics
Origin register
US FDA, United States
Storage
QUZYTTIR (cetirizine hydrochloride injection) should be stored at 20°C to 25°C (68°F to 77°F), excursions permitted to 15° - 30°C (59° - 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R06AE07 Cetirizine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
13 November 2019
Identifiers
RxCUI 2261746, 2261754DailyMed set ID 573770f6-b76e-f6ba-e063-6294a90aa54d, f33e859d-ebc9-4d4f-a57d-204c48760d20NDC 68118-200, 70720-100Application NDA211415

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial, glass in 1 carton / 1 mL in 1 vial, glass68118-200-10Esteve Pharmaceuticals2 April 2020
25 vial, glass in 1 carton / 1 mL in 1 vial, glass68118-200-25Esteve Pharmaceuticals13 November 2019
1 vial, glass in 1 carton / 1 mL in 1 vial, glass70720-100-10TerSera Therapeutics2 April 2020
25 vial, glass in 1 carton / 1 mL in 1 vial, glass70720-100-25TerSera Therapeutics13 November 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 8 December 1995Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Cetirizine

Clinical summary

Cetirizine is a histamine-1 receptor antagonist indicated for the treatment of ocular itching associated with allergic conjunctivitis. It is available as oral solution, injection and powder for ophthalmic solution for intravenous use. MedsAcross supplies Cetirizine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Cetirizine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Quzyttir 10 mg/1 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.